SNT Share Price Performance
zł303.20
83.20 (37.82%)
48.5% overvalued intrinsic discount
zł204.19
Fair Value
Price zł303.20
Phetuvov zł204.19
Fair Valuezł204.19
Share Pricen/a
Estimating The Fair Value Of Synektik Spólka Akcyjna (WSE:SNT)
Jan 09
Synektik Spólka Akcyjna Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 38 Fair Values set on narratives written by author
SNT Community Narratives
PH
Fair Value zł204.19 48.5% overvalued intrinsic discount
Cardiac marker could be a hit
1users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
Cardiac marker could be a hit
In 5 years, the company should still be thriving, entering new markets and expanding in existing ones. Positive passage of the third stage of testing of a new cardiac marker could help.Read more
212
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
PH
zł204.19
48.5% overvalued intrinsic discount
Phetuvov's Fair Value
Revenue
8.49% p.a.
Profit Margin
13%
Future PE
22x
Price in 2029
zł311.79
Trending Discussion
Recently Updated Narratives
PH
Cardiac marker could be a hit
Fair Value: zł204.19 48.5% overvalued intrinsic discount
8 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Synektik Spólka Akcyjna Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 12, 2026
- 14.78
- 35.73%
- 18.49%
- 6.9%
About SNT
- Founded
- 2001
- Employees
- 231
- CEO
- WebsiteView website
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as researches, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, the company operates a research laboratory for diagnostic imaging systems and a service center for medical equipment. Further, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in 2001 and is based in Warsaw, Poland.
